NASDAQ:COOL

Corner Growth Acquisition Competitors

Notice: This company has been marked as potentially delisted and may not be actively trading.
$9.99
+0.06 (+0.60 %)
(As of 04/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.86
Now: $9.99
$9.99
50-Day Range
$17.33
MA: $17.33
$17.33
52-Week Range
$15.21
Now: $9.99
$41.22
Volume54,837 shs
Average Volume679,141 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Corner Growth Acquisition (NASDAQ:COOL) Vs. ACHL, ADTX, CBDC, CDMOP, CANB, and CBGL

Should you be buying COOL stock or one of its competitors? Companies in the sector of "medical" are considered alternatives and competitors to Corner Growth Acquisition, including Achilles Therapeutics plc American Depositary Shares (ACHL), ADiTx Therapeutics (ADTX), Apotheca Biosciences (CBDC), Avid Bioservices (CDMOP), Can B (CANB), and Cannabis Global (CBGL).

Corner Growth Acquisition (NASDAQ:COOL) and Achilles Therapeutics plc American Depositary Shares (NASDAQ:ACHL) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations.

Insider and Institutional Ownership

43.1% of Corner Growth Acquisition shares are owned by institutional investors. 43.3% of Corner Growth Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Corner Growth Acquisition and Achilles Therapeutics plc American Depositary Shares' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Corner Growth AcquisitionN/AN/AN/A
Achilles Therapeutics plc American Depositary SharesN/AN/AN/A

Analyst Ratings

This is a breakdown of current recommendations for Corner Growth Acquisition and Achilles Therapeutics plc American Depositary Shares, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Corner Growth Acquisition0000N/A
Achilles Therapeutics plc American Depositary Shares0000N/A

Earnings and Valuation

This table compares Corner Growth Acquisition and Achilles Therapeutics plc American Depositary Shares' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Corner Growth AcquisitionN/AN/AN/AN/AN/A
Achilles Therapeutics plc American Depositary SharesN/AN/AN/AN/AN/A

Summary

Corner Growth Acquisition beats Achilles Therapeutics plc American Depositary Shares on 2 of the 2 factors compared between the two stocks.

ADiTx Therapeutics (NASDAQ:ADTX) and Corner Growth Acquisition (NASDAQ:COOL) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, valuation, earnings and dividends.

Insider and Institutional Ownership

43.1% of Corner Growth Acquisition shares are owned by institutional investors. 43.3% of Corner Growth Acquisition shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares ADiTx Therapeutics and Corner Growth Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ADiTx TherapeuticsN/AN/AN/A
Corner Growth AcquisitionN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings for ADiTx Therapeutics and Corner Growth Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ADiTx Therapeutics00103.00
Corner Growth Acquisition0000N/A

Valuation & Earnings

This table compares ADiTx Therapeutics and Corner Growth Acquisition's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ADiTx TherapeuticsN/AN/AN/AN/AN/A
Corner Growth AcquisitionN/AN/AN/AN/AN/A

Summary

Corner Growth Acquisition beats ADiTx Therapeutics on 2 of the 3 factors compared between the two stocks.

Apotheca Biosciences (NASDAQ:CBDC) and Corner Growth Acquisition (NASDAQ:COOL) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, valuation, earnings and dividends.

Insider and Institutional Ownership

43.1% of Corner Growth Acquisition shares are owned by institutional investors. 43.3% of Corner Growth Acquisition shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Apotheca Biosciences and Corner Growth Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Apotheca BiosciencesN/AN/AN/A
Corner Growth AcquisitionN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings for Apotheca Biosciences and Corner Growth Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Apotheca Biosciences0000N/A
Corner Growth Acquisition0000N/A

Valuation & Earnings

This table compares Apotheca Biosciences and Corner Growth Acquisition's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apotheca BiosciencesN/AN/AN/AN/AN/A
Corner Growth AcquisitionN/AN/AN/AN/AN/A

Summary

Corner Growth Acquisition beats Apotheca Biosciences on 2 of the 2 factors compared between the two stocks.

Avid Bioservices (NASDAQ:CDMOP) and Corner Growth Acquisition (NASDAQ:COOL) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, valuation, earnings and dividends.

Profitability

This table compares Avid Bioservices and Corner Growth Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Avid BioservicesN/AN/AN/A
Corner Growth AcquisitionN/AN/AN/A

Insider and Institutional Ownership

43.1% of Corner Growth Acquisition shares are owned by institutional investors. 43.3% of Corner Growth Acquisition shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Avid Bioservices and Corner Growth Acquisition's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avid BioservicesN/AN/AN/AN/AN/A
Corner Growth AcquisitionN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings for Avid Bioservices and Corner Growth Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Avid Bioservices0000N/A
Corner Growth Acquisition0000N/A

Summary

Corner Growth Acquisition beats Avid Bioservices on 2 of the 2 factors compared between the two stocks.

Can B (NASDAQ:CANB) and Corner Growth Acquisition (NASDAQ:COOL) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, risk and earnings.

Profitability

This table compares Can B and Corner Growth Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Can BN/AN/AN/A
Corner Growth AcquisitionN/AN/AN/A

Insider & Institutional Ownership

43.1% of Corner Growth Acquisition shares are held by institutional investors. 43.3% of Corner Growth Acquisition shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Can B and Corner Growth Acquisition's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Can BN/AN/AN/AN/AN/A
Corner Growth AcquisitionN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations and price targets for Can B and Corner Growth Acquisition, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Can B0000N/A
Corner Growth Acquisition0000N/A

Summary

Corner Growth Acquisition beats Can B on 2 of the 2 factors compared between the two stocks.

Cannabis Global (NASDAQ:CBGL) and Corner Growth Acquisition (NASDAQ:COOL) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, risk and earnings.

Profitability

This table compares Cannabis Global and Corner Growth Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cannabis GlobalN/AN/AN/A
Corner Growth AcquisitionN/AN/AN/A

Insider & Institutional Ownership

43.1% of Corner Growth Acquisition shares are held by institutional investors. 43.3% of Corner Growth Acquisition shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Cannabis Global and Corner Growth Acquisition's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cannabis GlobalN/AN/AN/AN/AN/A
Corner Growth AcquisitionN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations and price targets for Cannabis Global and Corner Growth Acquisition, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cannabis Global0000N/A
Corner Growth Acquisition0000N/A

Summary

Corner Growth Acquisition beats Cannabis Global on 2 of the 2 factors compared between the two stocks.


Corner Growth Acquisition Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
ACHL
Achilles Therapeutics plc American Depositary Shares
0.0$13.05+5.6%$0.00N/A0.00
ADiTx Therapeutics logo
ADTX
ADiTx Therapeutics
1.0$2.72+8.1%$0.00N/A0.00Gap Up
Apotheca Biosciences logo
CBDC
Apotheca Biosciences
0.4$0.08+0.0%$0.00N/A0.00
Avid Bioservices logo
CDMOP
Avid Bioservices
0.3$25.06+0.0%$0.00N/A0.00
Can B logo
CANB
Can B
0.4$0.56+1.8%$0.00N/A0.00Gap Up
Cannabis Global logo
CBGL
Cannabis Global
0.0$0.10+9.6%$0.00N/A0.00Gap Up
CareCloud logo
MTBCP
CareCloud
0.3$27.79+0.2%$0.00N/A0.00
FORA
Forian
0.3$12.44+8.2%$0.00N/A0.00News Coverage
Green Hygienics logo
GRYN
Green Hygienics
0.0$1.36+4.4%$0.00N/A0.00Gap Up
GLSI
Greenwich LifeSciences
1.7$39.15+36.9%$0.00N/A0.00High Trading Volume
News Coverage
Gap Up
Medigus logo
MDGS
Medigus
1.7$1.87+7.5%$0.00N/A0.00News Coverage
RPHM
Reneo Pharmaceuticals
0.0$12.75+8.9%$0.00N/A0.00High Trading Volume
Gap Up
SCPS
Scopus BioPharma
1.4$7.58+0.1%$0.00N/A0.00Gap Down
The Greater Cannabis logo
GCAN
The Greater Cannabis
0.6$0.01+3.1%$0.00N/A0.00
VECT
VectivBio
0.0$17.74+36.6%$0.00N/A0.00High Trading Volume
News Coverage
Gap Up
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.